Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yawara Kawano

Showing results (1-10 of 65) with videos related to

Pageof 7
Sort By:
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|May 10, 2021
[The role of regulatory T cells in multiple myeloma progression]Yawara Kawano
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|June 3, 2026
[Recent advances in management of systemic AL amyloidosis]Ayuko Naito, Yawara Kawano
Cancer Treatment and Research|October 4, 2016
Targeting the Bone Marrow MicroenvironmentMichele Moschetta, Yawara Kawano, Klaus Podar
International Journal of Hematology|November 17, 2025
Advances in immune microenvironment profiling during multiple myeloma progression and therapyJunzhe Bai, Nao Nishimura, Yawara Kawano
Clinical and Experimental Medicine|December 22, 2025
Clinical significance of t(11;14) translocation in systemic AL amyloidosis in the era of daratumumab therapyNao Nishimura, Yawara Kawano, Jun-Ichirou Yasunaga
International Journal of Hematology|May 13, 2024
Serum monoclonal immunoglobulin light-chain detection differs between immunofixation electrophoresis methods in patients with AL amyloidosisYawara Kawano, Nao Nishimura, Jun-Ichirou Yasunaga
Current Cancer Drug Targets|February 17, 2017
Multiple Myeloma and the Immune MicroenvironmentYawara Kawano, Aldo M Roccaro, Irene M Ghobrial, et al.
British Journal of Haematology|May 7, 2022
Daratumumab, lenalidomide and dexamethasone in newly diagnosed systemic light chain amyloidosis patients associated with multiple myelomaYawara Kawano, Hiroyuki Hata, Seiji Takashio, et al.
Current Opinion in Hematology|April 22, 2016
Cell autonomous and microenvironmental regulation of tumor progression in precursor states of multiple myelomaSalomon Manier, Yawara Kawano, Giada Bianchi, et al.
Biochemical and Biophysical Research Communications|December 7, 2021
A novel PDK1 inhibitor, JX06, inhibits glycolysis and induces apoptosis in multiple myeloma cellsYawara Kawano, Takayuki Sasano, Yuichiro Arima, et al.
Pageof 7

Showing results (1-10 of 65) with videos related to

Sort By:
Pageof 7
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|May 10, 2021
[The role of regulatory T cells in multiple myeloma progression]Yawara Kawano
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|June 3, 2026
[Recent advances in management of systemic AL amyloidosis]Ayuko Naito, Yawara Kawano
Cancer Treatment and Research|October 4, 2016
Targeting the Bone Marrow MicroenvironmentMichele Moschetta, Yawara Kawano, Klaus Podar
International Journal of Hematology|November 17, 2025
Advances in immune microenvironment profiling during multiple myeloma progression and therapyJunzhe Bai, Nao Nishimura, Yawara Kawano
Clinical and Experimental Medicine|December 22, 2025
Clinical significance of t(11;14) translocation in systemic AL amyloidosis in the era of daratumumab therapyNao Nishimura, Yawara Kawano, Jun-Ichirou Yasunaga
International Journal of Hematology|May 13, 2024
Serum monoclonal immunoglobulin light-chain detection differs between immunofixation electrophoresis methods in patients with AL amyloidosisYawara Kawano, Nao Nishimura, Jun-Ichirou Yasunaga
Current Cancer Drug Targets|February 17, 2017
Multiple Myeloma and the Immune MicroenvironmentYawara Kawano, Aldo M Roccaro, Irene M Ghobrial, et al.
British Journal of Haematology|May 7, 2022
Daratumumab, lenalidomide and dexamethasone in newly diagnosed systemic light chain amyloidosis patients associated with multiple myelomaYawara Kawano, Hiroyuki Hata, Seiji Takashio, et al.
Current Opinion in Hematology|April 22, 2016
Cell autonomous and microenvironmental regulation of tumor progression in precursor states of multiple myelomaSalomon Manier, Yawara Kawano, Giada Bianchi, et al.
Biochemical and Biophysical Research Communications|December 7, 2021
A novel PDK1 inhibitor, JX06, inhibits glycolysis and induces apoptosis in multiple myeloma cellsYawara Kawano, Takayuki Sasano, Yuichiro Arima, et al.
Pageof 7